XML 42 R26.htm IDEA: XBRL DOCUMENT v3.25.0.1
LOSS PER SHARE
 12 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
LOSS PER SHARE LOSS PER SHARE
Basic and diluted loss per share attributable to Bausch Health Companies Inc. for 2024, 2023 and 2022 was calculated as follows:
(in millions, except per share amounts)202420232022
Net loss attributable to Bausch Health Companies Inc.$(46)$(592)$(225)
Basic and diluted weighted-average common shares outstanding368.0 364.9 362.0 
Basic and diluted loss per share attributable to Bausch Health Companies Inc.$(0.13)$(1.62)$(0.62)
In 2024, 2023 and 2022, all potential common shares issuable for stock options and RSUs were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options and RSUs on the weighted-average number of common shares outstanding would have been approximately 3,142,000, 2,719,000 and 1,851,000 common shares for 2024, 2023 and 2022, respectively.
During 2024, 2023 and 2022, time-based RSUs, performance-based RSUs and stock options to purchase approximately 8,031,000, 13,864,000 and 14,396,000 common shares of the Company, respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method.
During 2023 and 2022, an additional 596,000 and 156,000 performance-based RSUs respectively, were not included in the computation of diluted earnings per share as the required performance conditions had not been met.